Inhibition of Allergic Inflammation by C-Terminal Peptides of the Prohormone Submandibular Rat 1 (SMR-1)

  title={Inhibition of Allergic Inflammation by C-Terminal Peptides of the Prohormone Submandibular Rat 1 (SMR-1)},
  author={R. E. Dery and R. Mathison and J. Davison and A. Befus},
  journal={International Archives of Allergy and Immunology},
  pages={201 - 204}
Background: The C-terminal of the prohormone submandibular rat 1 protein (SMR-1) contains several small peptides that reduce the severity of allergic inflammation and septic shock, and are part of the cervical sympathetic trunk-submandibular gland (SMG) axis of neuroendocrine immunology. These peptides include the heptapeptide, submandibular gland peptide-T and the tripeptide FEG. The D-isomeric form of this tripeptide, feG, which is active when administered orally, reduces LPS-provoked… Expand
22 Citations
Modulation of neutrophil function by the tripeptide feG
  • 28
The carboxamide feG(NH2) inhibits endotoxin perturbation of intestinal motility.
  • 7
Autonomic nervous system regulates secretion of anti-inflammatory prohormone SMR1 from rat salivary glands.
  • 11
Chronic use of the immunomodulating tripeptide feG-COOH in experimental feline asthma.
  • 16
  • Highly Influenced
Biomedical Research 2003; 14 (1): 30-37
feG-COOH blunts eosinophilic airway inflammation in a feline model of allergic asthma
  • 12
  • Highly Influenced
Effect of creatine, creatinine, and creatine ethyl ester on TLR expression in macrophages.
  • 17


A novel submandibular gland peptide protects against endotoxic and anaphylactic shock.
  • 31
Marked antiinflammatory effects of decentralization of the superior cervical ganglia
  • 44
  • PDF
Decentralization of the Superior Cervical Ganglia and the Immediate Hypersensitivity Response
  • 6
CD4+ T cells can induce airway hyperresponsiveness to allergen challenge in the brown norway rat.
  • 41
Integration of neuro-endocrine immune responses in defense of mucosal surfaces.
  • 9
Inflammation in asthma: the cornerstone of the disease and target of therapy.
  • W. Busse
  • Medicine
  • The Journal of allergy and clinical immunology
  • 1998
  • 111